Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049069552> ?p ?o ?g. }
- W3049069552 endingPage "1077" @default.
- W3049069552 startingPage "1065" @default.
- W3049069552 abstract "Program death 1 (PD-1)/ program death-ligand 1 (PD-L1) pathways, as the main inhibitory checkpoints, induce immunosuppression in the tumor microenvironment (TME). Despite the importance of inhibitor checkpoint receptor (ICR) blockers, their outcomes have been limited by the low immune response rate and induced acquired resistance. Pre-existing tumor-specific T cells is related to the improvement of their therapeutic efficacy. In the present study, we show that the combination of liposomal gp100 nanovaccine with anti PD-1 monoclonal antibody (mAb) potentiates the therapeutic effect in the melanoma model.In this study, we first decorate the cationic liposome with gp10025-33 self-antigen and then characterize it. Mice bearing B16F10 melanoma tumors were vaccinated with different formulations of gp100 peptide (free or liposomal form) with or without CpG ODN adjuvant in combination with anti PD-1 mAb.Therapeutic combination of liposomal nanovaccine and CpG with anti PD-1 mAb, demonstrated the increased number of tumor infiltrated lymphocytes (TILs) in TME with the highest IFN-γ production and cytotoxic activity, which led to remarkable tumor regression.Our results demonstrated the synergism between Lip-peptide+CpG nanovaccine and anti PD-1 regime, which improved the therapeutic efficacy of PD-1 checkpoint blocker in melanoma mice models." @default.
- W3049069552 created "2020-08-21" @default.
- W3049069552 creator A5005409842 @default.
- W3049069552 creator A5008272590 @default.
- W3049069552 creator A5014069997 @default.
- W3049069552 creator A5030493941 @default.
- W3049069552 creator A5035475970 @default.
- W3049069552 creator A5038430755 @default.
- W3049069552 creator A5048139853 @default.
- W3049069552 creator A5060364685 @default.
- W3049069552 creator A5081712132 @default.
- W3049069552 date "2020-08-01" @default.
- W3049069552 modified "2023-10-16" @default.
- W3049069552 title "Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy." @default.
- W3049069552 cites W1536488163 @default.
- W3049069552 cites W1875649129 @default.
- W3049069552 cites W1942897646 @default.
- W3049069552 cites W1944707476 @default.
- W3049069552 cites W1965235573 @default.
- W3049069552 cites W1970641459 @default.
- W3049069552 cites W1975499385 @default.
- W3049069552 cites W1976644560 @default.
- W3049069552 cites W1983460853 @default.
- W3049069552 cites W1984307295 @default.
- W3049069552 cites W1984545852 @default.
- W3049069552 cites W1985995901 @default.
- W3049069552 cites W1988711597 @default.
- W3049069552 cites W2004062771 @default.
- W3049069552 cites W2006403631 @default.
- W3049069552 cites W2006900932 @default.
- W3049069552 cites W2012698435 @default.
- W3049069552 cites W2014353818 @default.
- W3049069552 cites W2025964161 @default.
- W3049069552 cites W2030710574 @default.
- W3049069552 cites W2034550161 @default.
- W3049069552 cites W2039123767 @default.
- W3049069552 cites W2042108941 @default.
- W3049069552 cites W2046820608 @default.
- W3049069552 cites W2047584537 @default.
- W3049069552 cites W2049483717 @default.
- W3049069552 cites W2049491375 @default.
- W3049069552 cites W2051875277 @default.
- W3049069552 cites W2063511621 @default.
- W3049069552 cites W2066535225 @default.
- W3049069552 cites W2075633363 @default.
- W3049069552 cites W2077759816 @default.
- W3049069552 cites W2081979266 @default.
- W3049069552 cites W2090928701 @default.
- W3049069552 cites W2094746130 @default.
- W3049069552 cites W2096472814 @default.
- W3049069552 cites W2098351459 @default.
- W3049069552 cites W2098927214 @default.
- W3049069552 cites W2102439908 @default.
- W3049069552 cites W2102490154 @default.
- W3049069552 cites W2102886314 @default.
- W3049069552 cites W2103176338 @default.
- W3049069552 cites W2106183630 @default.
- W3049069552 cites W2113906692 @default.
- W3049069552 cites W2118011548 @default.
- W3049069552 cites W2118486765 @default.
- W3049069552 cites W2121805411 @default.
- W3049069552 cites W2123662098 @default.
- W3049069552 cites W2129523145 @default.
- W3049069552 cites W2131131389 @default.
- W3049069552 cites W2144547008 @default.
- W3049069552 cites W2144886433 @default.
- W3049069552 cites W2154203858 @default.
- W3049069552 cites W2156093138 @default.
- W3049069552 cites W2156222101 @default.
- W3049069552 cites W2156942570 @default.
- W3049069552 cites W2161684993 @default.
- W3049069552 cites W2165871546 @default.
- W3049069552 cites W2170240282 @default.
- W3049069552 cites W2174891711 @default.
- W3049069552 cites W2176718959 @default.
- W3049069552 cites W2277051575 @default.
- W3049069552 cites W2295202170 @default.
- W3049069552 cites W2534772180 @default.
- W3049069552 cites W2541860579 @default.
- W3049069552 cites W2562913827 @default.
- W3049069552 cites W2578528809 @default.
- W3049069552 cites W2586859946 @default.
- W3049069552 cites W2589014995 @default.
- W3049069552 cites W2757165350 @default.
- W3049069552 cites W2765749712 @default.
- W3049069552 cites W2765943070 @default.
- W3049069552 cites W2767533179 @default.
- W3049069552 cites W2798237214 @default.
- W3049069552 cites W2898618094 @default.
- W3049069552 cites W2918899673 @default.
- W3049069552 cites W2937318865 @default.
- W3049069552 doi "https://doi.org/10.22038/ijbms.2020.46654.10762" @default.
- W3049069552 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7478250" @default.
- W3049069552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32952954" @default.
- W3049069552 hasPublicationYear "2020" @default.
- W3049069552 type Work @default.
- W3049069552 sameAs 3049069552 @default.
- W3049069552 citedByCount "6" @default.